Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-023079

President and CEO sold 44,058 shares at $8.26 ($364,051)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
AUERBACH ALAN H President and CEO 2026-07-06 Sale 10b5-1 −44,058 $8.26 $364,051 7,261,671 D
Open-market sales · 44,058 sh · avg $8.26 · $364,051
Loading xslF345X06/rdgdoc.xml…